Five Prime Therapeutics, Inc. (FPRX) financial statements (2022 and earlier)

Company profile

Business Address 111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments287,259156,380270,138292,690421,748517,466149,054
Cash and cash equivalents69,42255,80043,95359,7907,653149,97115,267
Short-term investments217,837100,580226,185232,900414,095367,495133,787
Receivables854,0975,09613,1333,9594,054410
Other undisclosed current assets5,0646,24313,3345,36714,4186,7611,794
Total current assets:292,408166,720288,568311,190440,125528,281151,258
Noncurrent Assets
Operating lease, right-of-use asset21,27630,934
Property, plant and equipment11,20922,53428,71830,7626,2074,5393,794
Restricted cash and investments   1,5431,543  
Deferred costs     1,9001,700
Other noncurrent assets5,2142,4112,705552406394579
Other undisclosed noncurrent assets1,5431,5431,543  13,171(1,700)
Total noncurrent assets:39,24257,42232,96632,8578,15620,0044,373
TOTAL ASSETS:331,650224,142321,534344,047448,281548,285155,631
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,05917,64824,70336,91223,72661,0917,245
Accounts payable4731,1841,9722,2373341,8941,096
Accrued liabilities11,3859,65915,34827,51915,4355,8821,531
Employee-related liabilities5,2016,8057,3837,1567,9576,8784,618
Taxes payable     46,437 
Deferred revenue 1,296
Debt 4,080     
Deferred rent credit  1,356
Deferred revenue and credits14,06915,01518,27712,570
Contract with customer, liability1,428
Other undisclosed current liabilities5,125      
Total current liabilities:22,18423,02427,48750,98138,74179,36819,815
Noncurrent Liabilities
Long-term debt and lease obligation42,30945,532     
Operating lease, liability42,30945,532
Liabilities, other than long-term debt2,0575,11328,90827,86417,96532,42850,611
Deferred revenue and credits27,86417,85632,13350,142
Deferred revenue2,0575,113
Contract with customer, liability10,465
Deferred rent credit  18,443
Other liabilities    109295469
Total noncurrent liabilities:44,36650,64528,90827,86417,96532,42850,611
Total liabilities:66,55073,66956,39578,84556,706111,79670,426
Stockholders' equity
Stockholders' equity attributable to parent265,100150,473265,139265,202391,575433,20685,205
Common stock45353428272622
Additional paid in capital781,291582,243559,892421,257396,635372,605274,180
Accumulated other comprehensive income (loss)(25)78(106)(476)(39)(74)1
Retained earnings (accumulated deficit)(516,211)(431,883)(294,681)(155,607)(5,048)60,649(188,998)
Total stockholders' equity:265,100150,473265,139265,202391,575433,20685,205
Other undisclosed liabilities and equity     3,283 
TOTAL LIABILITIES AND EQUITY:331,650224,142321,534344,047448,281548,285155,631

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues13,17814,87449,86839,50830,691379,801 
Revenue, net39,50830,691379,801 
Gross profit:13,17814,87449,86839,50830,691379,801 
Operating expenses(106,048)(156,812)(196,023)(190,910)(129,903)(92,828)(56,805)
Other undisclosed operating income      19,231
Operating income (loss):(92,870)(141,938)(146,155)(151,402)(99,212)286,973(37,574)
Nonoperating income1,9124,7365,7082,8842,467484150
Investment income, nonoperating 4,7365,7082,9782,467487210
Other nonoperating income (expense)1,912  (94) (3)(60)
Income (loss) from continuing operations before income taxes:(90,958)(137,202)(140,447)(148,518)(96,745)287,457(37,424)
Income tax expense (benefit)6,630  (1,704)31,048(37,810) 
Net income (loss) available to common stockholders, diluted:(84,328)(137,202)(140,447)(150,222)(65,697)249,647(37,424)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(84,328)(137,202)(140,447)(150,222)(65,697)249,647(37,424)
Other comprehensive income (loss)(103)184370(437)35(75)(2)
Comprehensive income (loss), net of tax, attributable to parent:(84,431)(137,018)(140,077)(150,659)(65,662)249,572(37,426)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: